The popularity of omega-3 fatty acids EPA and DHA is growing hugely, largely due to the vast body of scientific evidence supporting their use. The health benefits offered by EPA and DHA are supported by more clinical data than commonly used pharmaceutical ingredients such as ibuprofen and simvastatin.
Increased media interest in new omega-3 studies has led to misinterpretation of results, creating media hype around prostate cancer and heart health risks.
Download this .pdf by Croda’s lead nutritionalist to discover why you shouldn’t believe everything you read in the media.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.